Hepatology

England reports progress towards hepatitis C elimination as prevalence falls, with diagnosis gaps and harm reduction challenges remaining.

Hepatitis E infection affected 3.5% of transplant patients, with high chronicity in those infected and treatment and screening key to care.

Global efforts to tackle viral hepatitis are insufficient, leaving millions at risk and far from 2030 elimination goals.

Paediatric autoimmune hepatitis incidence in Denmark has surged, yet most children maintain liver function with standard immunosuppressive therapy.

Underreported alcohol use masks alcohol-related liver disease, increasing misclassification and obscuring true mortality rates.

Telemedicine nutrition care reduces MASLD and liver disease risk in adults with type 2 diabetes and obesity, showing promise for lifestyle-first interventions.

In a northern Mexico cohort, MASLD now accounts for the largest share of chronic liver disease and cirrhosis cases.

Normothermic machine perfusion allows clinicians to assess high-risk livers from donors after circulatory or brain death before transplantation.